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The COVID-19 pandemic is placing immense pressure on
healthcare andpublic health systemsworldwide. In addition to
the COVID-19–related death toll and increased demand on
intensive care, the pandemic has major repercussions on
health outcomes of other diseases at times when resources
and personnel are diverted to COVID-19. This challenge is of
particular concern for low- and middle-income countries.
WHO has emphasized the need to sustain efforts to prevent,
detect, and treat vector-borne diseases, such as malaria,
during this pandemic.1 A similar approach should be adopted
for the prevention and control of dengue and other arboviral
diseases.
About 100 million dengue cases occur every year, with the
highest burden in Southeast Asia followed by Latin America.2
Epidemic transmission of both dengue and COVID-19 is
driven by population densities.2,3 Thus, the impact of com-
bined dengue and COVID-19 epidemics could have poten-
tially devastating consequences in tropical and subtropical
cities. Manifestations of this double burden are seen in
Guayaquil, Ecuador, and Iquitos, Peru, where an enormous
dengue season coincided with the spread of SARS-CoV-2,
and extreme excess mortality cannot be attributed only to
COVID-19.4 The dengue incidence rate was 12.86 cases/
100,000 inhabitants in the region for the ongoing year, in-
cluding 27 deaths, 12,891 cases confirmed by laboratory, and
498 cases classified as severe dengue (0.4%).4 Countries
such as Bolivia, Honduras, Mexico and Paraguay have re-
ported an increase of double or triple the number of cases of
dengue compared with the same period from the previous
year,5 and the humanitarian and migration crisis in Venezuela
has led to a breakdown in public health structures.6 Southeast
Asia is also battling a surge in dengue cases.
In the early stages, dengue and COVID-19 are difficult to
distinguish because they share similar clinical and laboratory
features early on. Both often initially present as undiffer-
entiated fever with nonspecific signs and symptoms;
shared laboratory parameters include lymphopenia, leuko-
penia, thrombocytopenia, and elevated transaminases.7 Sin-
gapore reported on patients being first incorrectly diagnosed
with dengue due to a false-positive dengue rapid serological
test who were later confirmed to be COVID-19.7 Misdiagnosis
ofCOVID-19 asdenguewith failure to isolate suchpatientswill
trigger outbreaks in healthcare settings and beyond. Failing to
recognize dengue and institute timely hydration may lead to
preventable dengue-related deaths. High awareness of den-
gue and application of virological tests to differentiate dengue
from COVID-19 is thus a priority in healthcare systems
throughout the tropics and subtropics. At the same time,
universal personal protectivemeasures need to be applied at
all times to prevent inadvertent SARS-CoV-2 transmission
in healthcare centers. Although severe outcomes for COVID-
19 appear to be predominantly in older persons,8 whereas
dengue affects more children and young adults in most
dengue-endemic countries,2 dengue has also emerged to be
a major cause of morbidity and mortality in the elderly in
places such as Singapore and Taiwan. A detailed and strict
triage algorithm to differentiate the diseases should be fol-
lowed. Coinfectionwith both viruses is possible and needs to
be excluded.
Although public health staff in many countries are currently
diverted to COVID-19 response, it is of utmost importance to
maintain and enhance mosquito control measures during the
pandemic. For countries where governments have introduced
lockdowns, special permissions should be sought to continue
vector control strategies. Vector control teams targeting
mosquito breeding sites should comply with social distancing
measures and wear personal protective equipment (PPE) if
entering houses for indoor residual insecticide spraying.
Wearing PPE in hot and humid climates is cumbersome. The
international community needs to develop new PPE ap-
proaches that are more amenable to such climates.
Teams conducting indoor residual spraying at the house-
hold level could combine this activity with active case detection
for COVID-19. Health messaging to enhance compliance to
COVID-19 public health measures should be combined with
messaging to enhance household and community participation
in vector control measures.
At a time of lockdowns when people are told to stay at
home, community participation in mosquito control activities
should be strengthened. Dengue transmission in and around
homes is considered a driving factor for dengue outbreaks.
Residents should be reminded of the mosquito life cycle, in-
cluding the aquatic phase of 6–10 days, and encouraged to
work together in and around their homes to remove stagnant
water, reduce solid waste and plastics that fill with rain, and
ensure proper covering of all water storage containers. The
intra-domicile application of targeted indoor residual spraying
should be selectively directed atAedes aegypti resting places,
such as under furniture and on dark surfaces. Precautions
must be taken not to fumigate drinking water storage tanks.
Tackling breeding sites at homes could become a weekly
family activity that should bemaintained even after lockdowns
are lifted. Vulnerable members within households such as the
elderly, pregnant women, infants, and those with underlying
medical conditions should be encouraged to use insect re-
pellents to protect themselves against mosquito bites. New
innovative strategies could be developed; for example, to
combine hand sanitizers against COVID-19 with insect re-
pellents against arboviral diseases vectors.
Studies have shown that buildings and sites beyond the
household level can be at increased risk for breeding and
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proliferation of mosquitoes if no one takes ownership for
vector control at those sites.9 This is particularly true for
schools, cemeteries, and construction sites.9,10 Many
lockdowns include school closures. It is important to
maintain vector control measures at such schools even
during closures to keep breeding sites at bay to prevent
dengue outbreaks when children return to school after the
lockdown. Regular cleaning and fumigation need to be
maintained at construction sites and cemeteries even
when regular work has been discontinued because of
lockdown.
In summary, a resurgence of dengue and other arboviral
diseases is a real threat during the COVID-19 pandemic be-
cause they add to overwhelming already fragile healthcare
systems. Lockdown periods should be leveraged as an op-
portunity to enhance vector control measures at the house-
hold level. At the community level, public health messaging
and community engagement should include both diseases. At
national and global levels, it is imperative to sustain effective
vector control measures.
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